Exogenous supplement of glucagon like peptide-1 protects the heart against aortic banding induced myocardial fibrosis and dysfunction through inhibiting mTOR/p70S6K signaling and promoting autophagy-Reference-Cited by-同舟云学术

Exogenous supplement of glucagon like peptide-1 protects the heart against aortic banding induced myocardial fibrosis and dysfunction through inhibiting mTOR/p70S6K signaling and promoting autophagy

Published:2020-09 Issue: Volume:883 Page:173318
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Zheng Rong-Hua,Zhang Wei-Wei,Ji Ye-Nan,Bai Xiao-Jie,Yan Cai-Ping,Wang Jin,Bai Feng,Zhao Zhi-Qing

Publisher

Elsevier BV

Subject

Pharmacology

Reference61 articles.

1. Effect of autophagy on myocardial infarction and its mechanism;Aisa;Eur. Rev. Med. Pharmacol. Sci.,2017

2. Rapamycin: an inhibitor of aging emerges from the soil of easter island;Arriola Apelo;J. Gerontol. A. Biol. Sci. Med. Sci.,2016

4. Dipeptidyl peptidase 4 inhibition alleviates shortage of circulating glucagon-like peptide-1 in heart failure and mitigates myocardial remodeling and apoptosis via the exchange protein directly activated by cyclic AMP 1/Ras-related protein 1 axis;Aoyama;Circ. Heart. Fail.,2016

5. mTORC1 signaling and the metabolic control of cell growth;Ben-Sahra;Curr. Opin. Cell Biol.,2017

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysregulation of pancreatic β-cell autophagy and the risk of type 2 diabetes;Autophagy;2024-06-18

2. Semaglutide ameliorates pressure overload-induced cardiac hypertrophy by improving cardiac mitophagy to suppress the activation of NLRP3 inflammasome;Scientific Reports;2024-05-23

3. Peptides Are Cardioprotective Drugs of the Future: The Receptor and Signaling Mechanisms of the Cardioprotective Effect of Glucagon-like Peptide-1 Receptor Agonists;International Journal of Molecular Sciences;2024-04-30

4. Emerging role of antidiabetic drugs in cardiorenal protection;Frontiers in Pharmacology;2024-02-06

5. GLP-1 receptor agonists and myocardial metabolism in atrial fibrillation;Journal of Pharmaceutical Analysis;2023-12